𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amnestic effects of lormetazepam and their reversal by the benzodiazepine antagonist Ro 15-1788

✍ Scribed by R. Dorow; D. Berenberg; T. Duka; N. Sauerbrey


Publisher
Springer
Year
1987
Tongue
English
Weight
889 KB
Volume
93
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Benzodiazepine antagonist RO 15-1788 par
✍ Catherine Belzung; Elise Vogel; RenΓ© Misslin πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 379 KB

The effects of the benzodiazepine (BZD) receptor antagonist RO 15-1788 (3 mg/kg) on the anxiolytic properties of ethanol in mice confronted with a light/dark choice procedure and with the staircase test were investigated. RO 15-1788 reversed the effects of ethanol on some of the behavioural paramete

Metabolism of the benzodiazepine antagon
✍ Carl-Gunnar Swahn; Anders Persson; Stefan Pauli πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 359 KB πŸ‘ 1 views

The metabolic fate of the benzodiazepine antagonist RO 15-1788 labelled with "C was studied in plasma from human subjects after intravenous administration in connection with positron emission tomography. R o 15-1788 and its metabolites were separated by thin-layer chromatography and the radioactivit

Changes in noradrenaline plasma levels a
✍ T. Duka; M. Ackenheil; J. Noderer; A. Doenicke; R. Dorow πŸ“‚ Article πŸ“… 1986 πŸ› Springer 🌐 English βš– 700 KB

Noradrenaline (NA) plasma levels were examined in 18 healthy volunteers on 2 consecutive days after a single treatment with either lormetazepam (0.06 mg/kg) (LMZ group), flunitrazepam (0.03 mg/kg) (FNZ group) or placebo (PLA group) in combination with the benzodiazepine (BZ) antagonist Ro 15-1788 (0